Arda Therapeutics
PrivateLast Round
Seed Round
Jun 3, 2026
Total Funding Raised
$50.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Arda Therapeutics is a biotechnology company that develops targeted therapies aimed at eliminating pathological cells responsible for chronic diseases by utilizing single-cell data to precisely target and remove these harmful cells without impacting healthy tissue.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arda Therapeutics Comparables
Compare Arda Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fibrocor Therapeutics | 78% | |
| Rubedo Life Sciences | 77% | |
| Mediar Therapeutics | 76% | |
Arda Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 3, 2026 | ||||
| Series A | Oct 1, 2024 | ||||
| Seed | Jan 25, 2022 |
Key People
Founding team and executive leadership
Arda Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A, Seed |
| LifeLink Ventures | Series A |
| GV | Series A, Seed |
| NJF Capital | Seed |
| Global Village | Seed |
| Gaingels | Series A |
| Mana Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Jun 3, 2026
$50K Seed Round raised.
Arda Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arda Therapeutics's valuation, stock price, and market status.